PR-Negative Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB06366 | Pertuzumab | 2 | Suspended | 1 |
| DB12893 | Sacituzumab govitecan | 2 | Recruiting | 1 |
| DB00072 | Trastuzumab | 2 | Suspended | 1 |
| DB05773 | Trastuzumab emtansine | 2 | Suspended | 1 |
| DB18457 | Zilovertamab vedotin | 2 | Completed | 1 |